Cargando…
The Use of Medications Approved for Alzheimer’s Disease in Autism Spectrum Disorder: A Systematic Review
Autism spectrum disorder (ASD) is a neurodevelopmental disorder that affects 1 in 68 children in the United States. Even though it is a common disorder, only two medications (risperidone and aripiprazole) are approved by the U.S. Food and Drug Administration (FDA) to treat symptoms associated with A...
Autores principales: | Rossignol, Daniel A., Frye, Richard E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4141213/ https://www.ncbi.nlm.nih.gov/pubmed/25202686 http://dx.doi.org/10.3389/fped.2014.00087 |
Ejemplares similares
-
Treatments for Biomedical Abnormalities Associated with Autism Spectrum Disorder
por: Frye, Richard Eugene, et al.
Publicado: (2014) -
The Effectiveness of Cobalamin (B12) Treatment for Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
por: Rossignol, Daniel A., et al.
Publicado: (2021) -
Environmental toxicants and autism spectrum disorders: a systematic review
por: Rossignol, D A, et al.
Publicado: (2014) -
A Systematic Review and Meta-Analysis of Immunoglobulin G Abnormalities and the Therapeutic Use of Intravenous Immunoglobulins (IVIG) in Autism Spectrum Disorder
por: Rossignol, Daniel A, et al.
Publicado: (2021) -
Mitochondrial dysfunction in autism spectrum disorders: a systematic review and meta-analysis
por: Rossignol, D A, et al.
Publicado: (2012)